News Tagged ‘simvastatin’

FDA warns of link between cholesterol drug, muscle injury

vytorin2 100x100More bad news for the -lowering drug Vytorin. The drug has been under scrutiny lately for everything from elevated cancer risk and serious side effects to ineffectiveness. This week, the Food and Drug Administration (FDA) issued a safety announcement about simvastatin, one of the two active ingredients found in the medication, and an increased risk of a potentially life-threatening muscle injury.

Read the rest of this entry »

FDA says it finds no Vytorin-cancer link, but unsure

fda logo 100x100The U.S. Food and Drug Administration announced today that it found no clear link between ’s blockbuster drug Vytorin and increased risk of cancer, but it could not rule out the possibility that such a link exists. The agency reviewed data from three trials, including the controversial SEAS trial results, which had withheld from the public for 18 months as it aggressively marketed the drug.

Read the rest of this entry »

Merck and Schering pay $41.5 million to settle NJ lawsuits

vytorin2 100x100 and , the pharmaceutical giants whose joint venture produced the blockbuster drug Vytorin, agreed to pay $41.5 million to settle 140-plus New Jersey lawsuits lodged against the manufacturers for misleading and improper marketing of the drug and for withholding the results of a clinical trial that showed to be a dud.

Read the rest of this entry »